Trial · NCT03819153
Adverse events2,046
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,046
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | COVID-19 | Infections and infestations | Semaglutide | 221 | 1,767 | 238 |
| other | COVID-19 | Infections and infestations | Placebo | 246 | 1,766 | 260 |
| other | Diabetic retinopathy | Eye disorders | Semaglutide | 339 | 1,767 | 394 |
| other | Diabetic retinopathy | Eye disorders | Placebo | 325 | 1,766 | 381 |
| serious | Abdominal distension | Gastrointestinal disorders | Semaglutide | 1 | 1,767 | 1 |
| serious | Abdominal distension | Gastrointestinal disorders | Placebo | 2 | 1,766 | 2 |
| serious | Abdominal hernia | Gastrointestinal disorders | Semaglutide | 1 | 1,767 | 1 |
| serious | Abdominal hernia | Gastrointestinal disorders | Placebo | 1 | 1,766 | 1 |
| serious | Abdominal hernia obstructive | Gastrointestinal disorders | Semaglutide | 0 | 1,767 | 0 |
| serious | Abdominal hernia obstructive | Gastrointestinal disorders | Placebo | 1 | 1,766 | 1 |
| serious | Abdominal hernia repair | Surgical and medical procedures | Semaglutide | 0 | 1,767 | 0 |
| serious | Abdominal hernia repair | Surgical and medical procedures | Placebo | 1 | 1,766 | 1 |
| serious | Abdominal incarcerated hernia | Gastrointestinal disorders | Semaglutide | 1 | 1,767 | 1 |
| serious | Abdominal incarcerated hernia | Gastrointestinal disorders | Placebo | 0 | 1,766 | 0 |
| serious | Abdominal pain | Gastrointestinal disorders | Semaglutide | 4 | 1,767 | 5 |
| serious | Abdominal pain | Gastrointestinal disorders | Placebo | 6 | 1,766 | 6 |
| serious | Abdominal pain lower | Gastrointestinal disorders | Semaglutide | 0 | 1,767 | 0 |
| serious | Abdominal pain lower | Gastrointestinal disorders | Placebo | 2 | 1,766 | 2 |
| serious | Abdominal pain upper | Gastrointestinal disorders | Semaglutide | 4 | 1,767 | 4 |
| serious | Abdominal pain upper | Gastrointestinal disorders | Placebo | 1 | 1,766 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03819153/events